FDA Releases Draft Guidance for Antibacterial Therapies for Patients with Unmet Medical Need

Summary

The FDA has made available a draft guidance document to help pharmaceutical companies develop new antibacterial treatments for serious bacterial diseases, particularly those with unmet medical needs, and pathogen-focused antibacterial drugs.